Vandetanib

Vandetanib is a targeted cancer medication used primarily to treat medullary thyroid cancer, a rare type of thyroid tumor. It works by blocking specific proteins (like RET and VEGFR) that help cancer cells grow and spread. By inhibiting these signals, Vandetanib slows down or stops tumor progression. It's usually given in pill form and is used under close medical supervision because it can cause side effects such as fatigue, rash, and high blood pressure. Overall, Vandetanib offers a focused approach to controlling certain thyroid cancers by interfering with their growth pathways.